Trial reportObesity surgery2026
Analgesic Effects of Intraperitoneal Bupivacaine Following Laparoscopic Bariatric Surgery: A Randomized Clinical Trial.
Trial report in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPostoperative pain is a significant concern following laparoscopic bariatric surgery. Effective analgesia is essential to facilitate recovery, reduce complications, and minimize opioid consumption, especially in patients with obesity who are more susceptible to respiratory compromise. This randomized clinical trial aimed to evaluate the efficacy of weight-standardized intraperitoneal instillation of local anesthetic (IPILA) using 0.2% bupivacaine in reducing postoperative pain among patients undergoing laparoscopic bariatric procedures.
methodsNinety adult patients undergoing bariatric surgery were randomly assigned to either an intervention group receiving intraperitoneal bupivacaine (0.5 mL/kg) or a control group receiving no instillation. Pain scores were measured using the Visual Analogue Scale (VAS) at recovery, and 2, 4, and 24 h postoperatively. Secondary outcomes included analgesic and antiemetic use after surgery.
resultsThe intervention group showed significantly lower VAS scores at recovery (2.2 ± 0.6 vs. 4.5 ± 1.2) and at 2 h (2.7 ± 1.2 vs. 4.1 ± 1.1) compared to the control group (p < 0.001). No significant difference was observed at 4 and 24 h. Analgesic and antiemetic requirements were similar between groups.
conclusionIntraperitoneal instillation of bupivacaine significantly reduces early postoperative pain after bariatric surgery without increasing complications or analgesic needs. While its effect does not extend beyond the immediate postoperative period, IPILA remains a simple, safe, and effective adjunct to multimodal analgesia protocols in bariatric patients for early postoperative pain control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.